Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation
Stress is a disturbance in homeostasis caused by psychological, physiological, or
environmental factors. Prolonged reactions to chronic stress can be detrimental, resulting in …
environmental factors. Prolonged reactions to chronic stress can be detrimental, resulting in …
Novel melatonin-based therapies: potential advances in the treatment of major depression
IB Hickie, NL Rogers - The Lancet, 2011 - thelancet.com
Major depression is one of the leading causes of premature death and disability. Although
available drugs are effective, they also have substantial limitations. Recent advances in our …
available drugs are effective, they also have substantial limitations. Recent advances in our …
Gender patterns in borderline personality disorder
RA Sansone, LA Sansone - Innovations in clinical …, 2011 - pmc.ncbi.nlm.nih.gov
Gender differences in patients with borderline personality disorder are potentially relevant
because they may guide clinicians in assessment and treatment. To date, a number of …
because they may guide clinicians in assessment and treatment. To date, a number of …
Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
D Taylor, A Sparshatt, S Varma, O Olofinjana - Bmj, 2014 - bmj.com
Objective To systematically review published and unpublished efficacy studies of
agomelatine in people with depression. Design Systematic review and meta-analysis. Data …
agomelatine in people with depression. Design Systematic review and meta-analysis. Data …
Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder
J Pierre Olié, S Kasper - International Journal of …, 2007 - academic.oup.com
Current antidepressants used in major depressive disorder (MDD) are still not efficacious
enough for many patients due to high levels of treatment resistance and bothersome side …
enough for many patients due to high levels of treatment resistance and bothersome side …
Depression subty** based on evolutionary psychiatry: Proximate mechanisms and ultimate functions
Major depressive disorder constitutes one of the leading causes of disability worldwide.
However, it is not a unitary disease—it is a heterogeneous syndrome, with patients differing …
However, it is not a unitary disease—it is a heterogeneous syndrome, with patients differing …
A randomised, double‐blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or …
SA Montgomery, RZ Nielsen… - Human …, 2014 - Wiley Online Library
Objective This randomised, double‐blind, 12‐week study compared efficacy and tolerability
of flexible‐dose treatment with vortioxetine (10–20 mg/day) versus agomelatine (25–50 …
of flexible‐dose treatment with vortioxetine (10–20 mg/day) versus agomelatine (25–50 …
Circadian rhythms and depression: human psychopathology and animal models
Most organisms (including humans) developed daily rhythms in almost every aspect of their
body. It is not surprising that rhythms are also related to affect in health and disease. In the …
body. It is not surprising that rhythms are also related to affect in health and disease. In the …
Application of antidepressants in depression: a systematic review and meta-analysis
Z Yuan, Z Chen, M Xue, J Zhang, L Leng - Journal of Clinical Neuroscience, 2020 - Elsevier
Background The type and quantities of antidepressants are increasing, but the efficacy and
safety of first-line and emerging drugs vary between studies. In this article, we estimated the …
safety of first-line and emerging drugs vary between studies. In this article, we estimated the …
Major depressive disorder, sleep EEG and agomelatine: an open-label study
MAQ Salva, B Vanier, J Laredo, S Hartley… - International journal …, 2007 - academic.oup.com
This open study evaluates the effect of agomelatine, a melatonergic receptor agonist and 5-
HT2C antagonist antidepressant, on sleep architecture in patients suffering from major …
HT2C antagonist antidepressant, on sleep architecture in patients suffering from major …